Ref ID: 17768
Author:
E. Agwu*, J. Inyang, J. Ihongbe
Author address:
(Ishaka, UG; Ekpoma, NG)
Full conference title:
22nd European Congress of Clinical Microbiology and Infectious Diseases
Abstract:
Background: The challenges of poor reduction of oral fungal load are
complicated by rampant report of refractile (Multidrug resistant) oropharyngeal
Candidiasis, permitting the need to search for possible
alternative to current treatment regimen.
Objective: To demonstrate a concentration of gentian-violate effective
against oral yeasts but not stigmatize the patients by painting the mouth
with blue/violate.
Methods: Department of Microbiology, Kampala International
University, supplied for this investigation, the 148 (100 Candida
albicans, 10 Candida glabrata, 10 Candida norvegiensis, 6 Candida
parapsilosis, 6 Zygosaccharamyces species, 5 Candida tropicalis, 5
Saccharomyces cerevesieae, 3 Candida sake and 3 Saccharomyces
kliuverii) clinical oral yeast samples previously recovered from the oral
lesions of HIV/AIDS patients attending clinics in South-Western
Uganda. Standard methods were used to test the serially diluted 0.5%
gentian violate solutions against the oral yeasts.
Results: It was observed that 1:32 was the least dilution of 0.5%
gentian-violate which was able to give the minimum sensitive 14 mm
zone diameter according to CLSI with Candida albicans. Again 14 mm
zone diameter was obtained from 1:10 dilution of C. glabrata and C.
sake; while 1:8 dilutions of C. tropicalis, C. norvegensis, and C. sake
respectively. Topical (1:32 dilution of 0.5% GV) antifungal alternative
is cheap, available and will not stain the mouth thus removing
associated stigma.
Conclusion: Therefore, 1:32 dilution of 0.5% gentian-violate can be
used as topical anti-Candida albicans and 1:8 dilution of GV as topicalanti-
non Candida albicans respectively. This assures the efficacy,
availability and sustainability of oral fungal lesions treatment in
resource poor setting.
Abstract Number: NULL
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a